Safety study of a large dose of vitamin D administered to hemodialysis patients and assessment of its effects on the parameters of bone abnormalities

Not Applicable

Completed

• Conditions: Hypovitaminosis D and secondary hyperparathyroidism; Nutritional, Metabolic, Endocrine; Vitamin D deficiency, Secondary hyperparathyroidism, not elsewhere classified

• Registration Number: ISRCTN10043222
• Lead Sponsor: niversity of Sharjah

Brief Summary

2023 Results article in https://doi.org/10.18549/pharmpract.2023.1.2773 (added 05/03/2024)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-12-31
• Study Start: 2022-02-18
• Last Update Posted: 18 March 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

1. Hemodialysis patients
2. On dialysis for more than 1 year
3. Not on active Vitamin D
4. Not on calcimimetics

Exclusion Criteria

1. Tertiary hyperparathyroidism
2. Ongoing debilitating condition (e.g. cancer)

Study & Design

• Study Type: Interventional
• Study Design: Not specified